|
371 |
NHS: new CDF means faster access to innovative treatments
Enthalten in PharmacoEconomics & outcomes news Bd. 796, 10.2.2018, Nr. 1, date:2.2018: 34
|
|
|
|
372 |
NICE issues draft policy on managing conflicts of interest
Enthalten in PharmacoEconomics & outcomes news Bd. 783, 29.7.2017, Nr. 1, date:7.2017: 7
|
|
|
|
373 |
NICE issues new guidance for asthma
Enthalten in PharmacoEconomics & outcomes news Bd. 793, 16.12.2017, Nr. 1, date:12.2017: 35
|
|
|
|
374 |
NICE launches new health-check service for economic models
Enthalten in PharmacoEconomics & outcomes news Bd. 793, 16.12.2017, Nr. 1, date:12.2017: 2
|
|
|
|
375 |
NICE recommends gene therapy for 'bubble baby syndrome'
Enthalten in PharmacoEconomics & outcomes news Bd. 794, 13.1.2018, Nr. 1, date:1.2018: 38
|
|
|
|
376 |
Nivolumab highly cost effective for renal cancer in Scotland
Enthalten in PharmacoEconomics & outcomes news Bd. 793, 16.12.2017, Nr. 1, date:12.2017: 21
|
|
|
|
377 |
Nützliches für die Hausarztmedizin
Enthalten in MMW - Fortschritte der Medizin Bd. 159, 12.9.2017, Nr. 15, date:9.2017: 3
|
|
|
|
378 |
Obesity increases economic burden of DM in the US
Enthalten in PharmacoEconomics & outcomes news Bd. 793, 16.12.2017, Nr. 1, date:12.2017: 23
|
|
|
|
379 |
Observed drug expenditure lower than company estimate
Enthalten in PharmacoEconomics & outcomes news Bd. 793, 16.12.2017, Nr. 1, date:12.2017: 24
|
|
|
|
380 |
OLT complications substantial financial burden
Enthalten in PharmacoEconomics & outcomes news Bd. 796, 10.2.2018, Nr. 1, date:2.2018: 20
|
|
Administration
